Skip to main content
Erschienen in: Clinical and Experimental Nephrology 5/2012

01.10.2012 | Original Article

Differences in the local and national prevalences of chronic kidney disease based on annual health check program data

verfasst von: Minako Wakasugi, Junichiro James Kazama, Ichiei Narita

Erschienen in: Clinical and Experimental Nephrology | Ausgabe 5/2012

Einloggen, um Zugang zu erhalten

Abstract

Background

Chronic kidney disease (CKD) is now recognized as a global public health problem, and evaluating the prevalence of CKD at the local level is important and helpful for assessing health care needs and targeted interventions. To assess the current picture concerning CKD in a local area, local and national prevalences of CKD were compared by calculating standardized rate ratios (SRRs) and confidence intervals (CIs).

Methods

For the national prevalence of CKD, the data from a previous report that showed age- and sex-specific prevalence of each stage of CKD on the basis of a large dataset from the Japanese annual health check program were used. Using annual health check program data in Sado City, the SRRs and CIs were calculated.

Results

The SRRs were 0.70 for males and 0.60 for females, indicating that Sado City had a 30 % lower prevalence of CKD for males and a 40 % lower for females than the national average. The 95 % CIs of the SRRs were calculated as 0.64–0.72 for males and 0.55–0.64 for females. Thus, the prevalence of CKD for both males and females in Sado City is significantly lower than the national average for Japan.

Conclusions

Because this methodology adjusts for age and sex, it can serve as a useful tool to assess the current picture related to CKD in a local area. We believe that this could be an important step for improving local care to prevent the development of CKD.
Literatur
1.
Zurück zum Zitat Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.PubMedCrossRef Imai E, Horio M, Watanabe T, Iseki K, Yamagata K, Hara S, Ura N, Kiyohara Y, Moriyama T, Ando Y, Fujimoto S, Konta T, Yokoyama H, Makino H, Hishida A, Matsuo S. Prevalence of chronic kidney disease in the Japanese general population. Clin Exp Nephrol. 2009;13:621–30.PubMedCrossRef
2.
Zurück zum Zitat Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–305.PubMedCrossRef
3.
Zurück zum Zitat Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, Kanashiki M, Saito Y, Ota H, Nose T. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69:1264–71.PubMedCrossRef Irie F, Iso H, Sairenchi T, Fukasawa N, Yamagishi K, Ikehara S, Kanashiki M, Saito Y, Ota H, Nose T. The relationships of proteinuria, serum creatinine, glomerular filtration rate with cardiovascular disease mortality in Japanese general population. Kidney Int. 2006;69:1264–71.PubMedCrossRef
5.
Zurück zum Zitat Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.PubMedCrossRef
6.
Zurück zum Zitat Breslow NE, Day NE. Rates and rate standardization. In: Statistical methods in cancer research, volume II: the design and analysis of cohort studies. Lyon: International Agency for Research on Cancer; 1987. p. 48–79. Breslow NE, Day NE. Rates and rate standardization. In: Statistical methods in cancer research, volume II: the design and analysis of cohort studies. Lyon: International Agency for Research on Cancer; 1987. p. 48–79.
7.
Zurück zum Zitat Wolfe RA. The standardized mortality ratio revisited: improvements, innovations, and limitations. Am J Kidney Dis. 1994;24:290–7.PubMed Wolfe RA. The standardized mortality ratio revisited: improvements, innovations, and limitations. Am J Kidney Dis. 1994;24:290–7.PubMed
8.
Zurück zum Zitat Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, Ohe K, Nagai R. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J. 2008;49:193–203.PubMedCrossRef Kohro T, Furui Y, Mitsutake N, Fujii R, Morita H, Oku S, Ohe K, Nagai R. The Japanese national health screening and intervention program aimed at preventing worsening of the metabolic syndrome. Int Heart J. 2008;49:193–203.PubMedCrossRef
9.
Zurück zum Zitat Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007. Am J Kidney Dis. 2007;49:175–9.PubMedCrossRef Levey AS, Andreoli SP, DuBose T, Provenzano R, Collins AJ. Chronic kidney disease: common, harmful and treatable—World Kidney Day 2007. Am J Kidney Dis. 2007;49:175–9.PubMedCrossRef
10.
Zurück zum Zitat Wakasugi M, Kazama JJ, Narita I. Use of Japanese Society for Dialysis Therapy dialysis tables to compare the local and national incidence of dialysis. Ther Apher Dial. 2012;16:63–7.PubMedCrossRef Wakasugi M, Kazama JJ, Narita I. Use of Japanese Society for Dialysis Therapy dialysis tables to compare the local and national incidence of dialysis. Ther Apher Dial. 2012;16:63–7.PubMedCrossRef
11.
Zurück zum Zitat Hallan SI, Vikse BE. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Curr Opin Nephrol Hypertens. 2008;17:286–91.PubMedCrossRef Hallan SI, Vikse BE. Relationship between chronic kidney disease prevalence and end-stage renal disease risk. Curr Opin Nephrol Hypertens. 2008;17:286–91.PubMedCrossRef
12.
Zurück zum Zitat Julious SA, Nicholl J, George S. Why do we continue to use standardized mortality ratios for small area comparisons? J Public Health Med. 2001;23:40–6.PubMedCrossRef Julious SA, Nicholl J, George S. Why do we continue to use standardized mortality ratios for small area comparisons? J Public Health Med. 2001;23:40–6.PubMedCrossRef
13.
Zurück zum Zitat Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100.PubMedCrossRef Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2005;67:2089–100.PubMedCrossRef
Metadaten
Titel
Differences in the local and national prevalences of chronic kidney disease based on annual health check program data
verfasst von
Minako Wakasugi
Junichiro James Kazama
Ichiei Narita
Publikationsdatum
01.10.2012
Verlag
Springer Japan
Erschienen in
Clinical and Experimental Nephrology / Ausgabe 5/2012
Print ISSN: 1342-1751
Elektronische ISSN: 1437-7799
DOI
https://doi.org/10.1007/s10157-012-0628-0

Weitere Artikel der Ausgabe 5/2012

Clinical and Experimental Nephrology 5/2012 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Reizdarmsyndrom: Diäten wirksamer als Medikamente

29.04.2024 Reizdarmsyndrom Nachrichten

Bei Reizdarmsyndrom scheinen Diäten, wie etwa die FODMAP-arme oder die kohlenhydratreduzierte Ernährung, effektiver als eine medikamentöse Therapie zu sein. Das hat eine Studie aus Schweden ergeben, die die drei Therapieoptionen im direkten Vergleich analysierte.

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.